Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Soft Tissue Infections 1Lymphoma, Follicular 1Infections 1Fournier Gangrene 1Fasciitis, Necrotizing 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 5Ciprofloxacin 4gamma-Globulins 3Voriconazole 3Caspofungin 3Amoxicillin-Potassium Clavulanate Combination 3liposomal amphotericin B 2Polymerase Chain Reaction 2Pentetic Acid 2Moxifloxacin 2Levofloxacin 2Itraconazole 2Immunoglobulins, Intravenous 2Fluconazole 2fludarabine phosphate 1ethanolamine oleate 1amphotericin B, deoxycholate drug combination 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Valacyclovir 1Trimethoprim 1Therapeutics 1Tazobactam 1Tacrolimus 1Sulfamethoxazole 1Sodium Chloride 1Sirolimus 1Saline Solution, Hypertonic 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × Daptomycin × Lymphoid × Clear all
NCT00261807 2022-01-27

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

University of Maryland, Baltimore

Phase NA Completed
25 enrolled 7 charts
Lymphoid

Infections, Lymphoma, Follicular, Soft Tissue Infections, Fournier Gangrene, Fasciitis, Necrotizing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡